Ardevora Asset Management LLP Bio Rad Laboratories, Inc. Transaction History

Ardevora Asset Management LLP

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 06, 2023	SELL	$359.49 - $486.4 $4.68 Million - $6.33 Million	-13,014 Reduced 12.35%	92,340 $35 Million
Q1 2023 Apr 20, 2023	SELL	$418.69 - $503.0 $3.68 Million - $4.42 Million	-8,793 Reduced 7.7%	105,354 $50.5 Million
Q4 2022 Jan 12, 2023	BUY	$351.71 - $456.01 $3.49 Million - $4.52 Million	9,918 Added 9.52%	114,147 $48 Million
Q3 2022 Nov 04, 2022	SELL	$412.59 - $563.26 $3.18 Million - $4.35 Million	-7,719 Reduced 6.9%	104,229 $43.5 Million
Q2 2022 Jul 11, 2022	BUY	$463.67 - $597.16 $1.95 Million - $2.51 Million	4,200 Added 3.9%	111,948 $55.4 Million
Q1 2022 Apr 28, 2022	BUY	$524.57 - $735.42 $1.76 Million - $2.47 Million	3,358 Added 3.22%	107,748 $60.7 Million
Q4 2021 Jan 31, 2022	BUY	$708.84 - $794.68 $637,956 - $715,212	900 Added 0.87%	104,390 $78.9 Million
Q3 2021 Oct 15, 2021	SELL	$657.71 - $825.77 $9.87 Million - $12.4 Million	-15,000 Reduced 12.66%	103,490 $77.2 Million
Q2 2021 Jul 22, 2021	BUY	$576.64 - $649.04 $15 Million - $16.8 Million	25,933 Added 28.02%	118,490 $76.3 Million
Q1 2021 Apr 22, 2021	SELL	$547.01 - $662.35 $1.7 Million - $2.05 Million	-3,100 Reduced 3.24%	92,557 $52.9 Million
Q4 2020 Jan 14, 2021	SELL	$510.68 - $643.45 $5.16 Million - $6.5 Million	-10,100 Reduced 9.55%	95,657 $55.8 Million
Q3 2020 Nov 05, 2020	BUY	$454.43 - $535.6 $408,987 - $482,040	900 Added 0.86%	105,757 $54.5 Million
Q2 2020 Jul 28, 2020	BUY	$334.87 - $493.06 $35.1 Million - $51.7 Million	104,857 New	104,857 $47.3 Million

457

18.2M

19.5K

13.9K

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $8.37B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

Get notified when there are updates to the investment portfolio of Ardevora Asset Management LLP, based on Form 13F filings with the SEC.

Stay updated on Ardevora Asset Management LLP with notifications on news.